Novel motif:19: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{ | |||
Latest revision as of 14:35, 9 September 2013
name: | motif19_GYTGGMC |
---|
Association to promoter expression in human samples<b>Summary:</b>Significance of the correlation with CAGE expression, human <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
Association to promoter expression in mouse samples
<b>Summary:</b>Significance of the correlation with CAGE expression, mouse <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
GREAT analysis results for human
<b>Summary:</b>Genomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon<br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0070208 | protein heterotrimerization | 9.370542e-12 |
GO:0051291 | protein heterooligomerization | 2.025191e-10 |
GO:0046724 | oxalic acid secretion | 2.315408e-10 |
GO:0019265 | glycine biosynthetic process, by transamination of glyoxylate | 2.315408e-10 |
GO:0032964 | collagen biosynthetic process | 6.477638e-10 |
GO:0042744 | hydrogen peroxide catabolic process | 7.347922e-10 |
GO:0003108 | negative regulation of the force of heart contraction by chemical signal | 1.325009e-9 |
GO:0006548 | histidine catabolic process | 1.589984e-9 |
GO:0006779 | porphyrin-containing compound biosynthetic process | 1.958975e-9 |
GO:0000302 | response to reactive oxygen species | 3.556359e-9 |
GO:0016056 | rhodopsin mediated signaling pathway | 4.384889e-9 |
GO:0006545 | glycine biosynthetic process | 4.464329e-9 |
GO:0002679 | respiratory burst involved in defense response | 7.370515e-9 |
GO:0002149 | hypochlorous acid biosynthetic process | 8.290077e-9 |
GO:0035691 | macrophage migration inhibitory factor signaling pathway | 1.677143e-8 |
GO:0042542 | response to hydrogen peroxide | 2.773756e-8 |
GO:0042743 | hydrogen peroxide metabolic process | 3.299819e-8 |
GO:0051295 | establishment of meiotic spindle localization | 3.402587e-8 |
GO:0010812 | negative regulation of cell-substrate adhesion | 7.442553e-8 |
GO:0032042 | mitochondrial DNA metabolic process | 8.716909e-8 |
GO:0060251 | regulation of glial cell proliferation | 9.925594e-8 |
GO:0002606 | positive regulation of dendritic cell antigen processing and presentation | 1.027862e-7 |
GO:0070206 | protein trimerization | 1.140986e-7 |
GO:0032796 | uropod organization | 1.233994e-7 |
GO:0006982 | response to lipid hydroperoxide | 1.271585e-7 |
GO:0060253 | negative regulation of glial cell proliferation | 1.485177e-7 |
GO:0006544 | glycine metabolic process | 1.513093e-7 |
GO:0006707 | cholesterol catabolic process | 1.990649e-7 |
GO:0006264 | mitochondrial DNA replication | 2.149963e-7 |
GO:0007132 | meiotic metaphase I | 2.479590e-7 |
GO:0060730 | regulation of intestinal epithelial structure maintenance | 2.508561e-7 |
GO:0060456 | positive regulation of digestive system process | 2.620773e-7 |
GO:0007140 | male meiosis | 2.639288e-7 |
GO:2000343 | positive regulation of chemokine (C-X-C motif) ligand 2 production | 3.054737e-7 |
GO:0042790 | transcription of nuclear large rRNA transcript from RNA polymerase I promoter | 3.582485e-7 |
GO:0010624 | regulation of Schwann cell proliferation | 3.895941e-7 |
GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline | 4.458400e-7 |
GO:0016125 | sterol metabolic process | 4.516893e-7 |
GO:0034465 | response to carbon monoxide | 5.050154e-7 |
GO:0071299 | cellular response to vitamin A | 5.536763e-7 |
GO:0071300 | cellular response to retinoic acid | 5.762012e-7 |
GO:0070715 | sodium-dependent organic cation transport | 6.165514e-7 |
GO:0052106 | quorum sensing involved in interaction with host | 6.165514e-7 |
GO:0060731 | positive regulation of intestinal epithelial structure maintenance | 6.165514e-7 |
GO:0042487 | regulation of odontogenesis of dentine-containing tooth | 7.138805e-7 |
GO:0072364 | regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter | 7.285051e-7 |
GO:0006778 | porphyrin-containing compound metabolic process | 7.457370e-7 |
GO:0006706 | steroid catabolic process | 8.063082e-7 |
GO:0019884 | antigen processing and presentation of exogenous antigen | 8.495739e-7 |
GO:0072365 | regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter | 9.084526e-7 |
GO:0009226 | nucleotide-sugar biosynthetic process | 1.062695e-6 |
GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II | 1.068629e-6 |
GO:0006547 | histidine metabolic process | 1.196274e-6 |
GO:0010872 | regulation of cholesterol esterification | 1.315088e-6 |
GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus | 1.352280e-6 |
GO:0051954 | positive regulation of amine transport | 1.391415e-6 |
GO:0001768 | establishment of T cell polarity | 1.398406e-6 |
GO:0030007 | cellular potassium ion homeostasis | 1.497080e-6 |
GO:0042268 | regulation of cytolysis | 1.519034e-6 |
GO:0070544 | histone H3-K36 demethylation | 1.713642e-6 |
GO:0071731 | response to nitric oxide | 1.813751e-6 |
GO:0045794 | negative regulation of cell volume | 2.014398e-6 |
GO:0046487 | glyoxylate metabolic process | 2.044988e-6 |
GO:0042699 | follicle-stimulating hormone signaling pathway | 2.071308e-6 |
GO:0032526 | response to retinoic acid | 2.112297e-6 |
GO:0033189 | response to vitamin A | 2.394585e-6 |
GO:0046314 | phosphocreatine biosynthetic process | 2.446158e-6 |
GO:0033013 | tetrapyrrole metabolic process | 2.717362e-6 |
GO:0019673 | GDP-mannose metabolic process | 2.996501e-6 |
GO:0002478 | antigen processing and presentation of exogenous peptide antigen | 3.203428e-6 |
GO:0046501 | protoporphyrinogen IX metabolic process | 3.557888e-6 |
GO:0016446 | somatic hypermutation of immunoglobulin genes | 3.736004e-6 |
GO:0002238 | response to molecule of fungal origin | 4.278265e-6 |
GO:0006884 | cell volume homeostasis | 4.597063e-6 |
GO:0071732 | cellular response to nitric oxide | 5.035961e-6 |
GO:0006617 | SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition | 5.037482e-6 |
GO:0006616 | SRP-dependent cotranslational protein targeting to membrane, translocation | 5.037482e-6 |
GO:0055075 | potassium ion homeostasis | 5.348750e-6 |
GO:0002579 | positive regulation of antigen processing and presentation | 5.475206e-6 |
GO:0006783 | heme biosynthetic process | 5.697809e-6 |
GO:0007126 | meiosis | 7.008172e-6 |
GO:0010626 | negative regulation of Schwann cell proliferation | 7.019724e-6 |
GO:0010873 | positive regulation of cholesterol esterification | 7.186854e-6 |
GO:0051323 | metaphase | 7.525071e-6 |
GO:0051321 | meiotic cell cycle | 7.526622e-6 |
GO:0000212 | meiotic spindle organization | 7.544604e-6 |
GO:0019835 | cytolysis | 7.620994e-6 |
GO:0071827 | plasma lipoprotein particle organization | 7.875475e-6 |
GO:0006772 | thiamine metabolic process | 8.077118e-6 |
GO:0031442 | positive regulation of mRNA 3'-end processing | 8.109571e-6 |
GO:0043585 | nose morphogenesis | 8.212396e-6 |
GO:0002906 | negative regulation of mature B cell apoptosis | 8.385286e-6 |
GO:0006013 | mannose metabolic process | 8.824891e-6 |
GO:0019511 | peptidyl-proline hydroxylation | 9.108191e-6 |
GO:0009070 | serine family amino acid biosynthetic process | 9.545608e-6 |
GO:0009155 | purine deoxyribonucleotide catabolic process | 9.825831e-6 |
GO:0034505 | tooth mineralization | 1.077863e-5 |
GO:2000427 | positive regulation of apoptotic cell clearance | 1.083738e-5 |
GO:0009301 | snRNA transcription | 1.098866e-5 |
GO:0050768 | negative regulation of neurogenesis | 1.108594e-5 |
GO:0070904 | transepithelial L-ascorbic acid transport | 1.108599e-5 |
GO:0060014 | granulosa cell differentiation | 1.154446e-5 |
GO:0042866 | pyruvate biosynthetic process | 1.154446e-5 |
GO:0032094 | response to food | 1.204003e-5 |
GO:0048545 | response to steroid hormone stimulus | 1.208755e-5 |
GO:0043503 | skeletal muscle fiber adaptation | 1.227462e-5 |
GO:0071417 | cellular response to organic nitrogen | 1.252455e-5 |
GO:0033326 | cerebrospinal fluid secretion | 1.295437e-5 |
GO:0060213 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening | 1.303616e-5 |
GO:0051259 | protein oligomerization | 1.541422e-5 |
GO:0009264 | deoxyribonucleotide catabolic process | 1.599469e-5 |
GO:0031064 | negative regulation of histone deacetylation | 1.697129e-5 |
GO:0042351 | 'de novo' GDP-L-fucose biosynthetic process | 1.859758e-5 |
GO:0010269 | response to selenium ion | 1.862189e-5 |
GO:0034379 | very-low-density lipoprotein particle assembly | 1.946301e-5 |
GO:0065002 | intracellular protein transmembrane transport | 2.023320e-5 |
GO:0006298 | mismatch repair | 2.055948e-5 |
GO:0002019 | regulation of renal output by angiotensin | 2.098924e-5 |
GO:0071295 | cellular response to vitamin | 2.121632e-5 |
GO:0002604 | regulation of dendritic cell antigen processing and presentation | 2.151703e-5 |
GO:0051591 | response to cAMP | 2.205375e-5 |
GO:0010916 | negative regulation of very-low-density lipoprotein particle clearance | 2.360964e-5 |
GO:0042396 | phosphagen biosynthetic process | 2.463537e-5 |
GO:0007520 | myoblast fusion | 2.521437e-5 |
GO:0043001 | Golgi to plasma membrane protein transport | 2.560318e-5 |
GO:0071418 | cellular response to amine stimulus | 2.570628e-5 |
GO:0015879 | carnitine transport | 2.572124e-5 |
GO:0044241 | lipid digestion | 2.660274e-5 |
GO:0014902 | myotube differentiation | 2.671341e-5 |
GO:0008203 | cholesterol metabolic process | 2.943748e-5 |
GO:0006002 | fructose 6-phosphate metabolic process | 2.973026e-5 |
GO:0044240 | multicellular organismal lipid catabolic process | 2.986831e-5 |
GO:0031960 | response to corticosteroid stimulus | 3.071485e-5 |
GO:0006694 | steroid biosynthetic process | 3.102280e-5 |
GO:0050685 | positive regulation of mRNA processing | 3.185066e-5 |
GO:0008033 | tRNA processing | 3.187479e-5 |
GO:0072044 | collecting duct development | 3.304915e-5 |
GO:0046731 | passive induction of host immune response by virus | 3.322751e-5 |
GO:0001839 | neural plate morphogenesis | 3.427871e-5 |
GO:0034227 | tRNA thio-modification | 3.448590e-5 |
GO:0002098 | tRNA wobble uridine modification | 3.448590e-5 |
GO:0018293 | protein-FAD linkage | 4.054412e-5 |
GO:0006121 | mitochondrial electron transport, succinate to ubiquinone | 4.054412e-5 |
GO:0007127 | meiosis I | 4.184931e-5 |
GO:0033605 | positive regulation of catecholamine secretion | 4.244084e-5 |
GO:0021516 | dorsal spinal cord development | 4.396937e-5 |
GO:0002740 | negative regulation of cytokine secretion involved in immune response | 4.406311e-5 |
GO:0060621 | negative regulation of cholesterol import | 4.455061e-5 |
GO:0044058 | regulation of digestive system process | 4.633764e-5 |
GO:0060620 | regulation of cholesterol import | 4.673993e-5 |
GO:0061014 | positive regulation of mRNA catabolic process | 4.787593e-5 |
GO:0033700 | phospholipid efflux | 4.950767e-5 |
GO:0001560 | regulation of cell growth by extracellular stimulus | 4.956705e-5 |
GO:0030917 | midbrain-hindbrain boundary development | 5.137338e-5 |
GO:0043000 | Golgi to plasma membrane CFTR protein transport | 5.153278e-5 |
GO:0070301 | cellular response to hydrogen peroxide | 5.239920e-5 |
GO:0035966 | response to topologically incorrect protein | 5.464034e-5 |
GO:0021527 | spinal cord association neuron differentiation | 5.730998e-5 |
GO:0035914 | skeletal muscle cell differentiation | 5.804425e-5 |
GO:0071638 | negative regulation of monocyte chemotactic protein-1 production | 5.972774e-5 |
GO:0042407 | cristae formation | 5.972774e-5 |
GO:0035726 | common myeloid progenitor cell proliferation | 5.972774e-5 |
GO:0035732 | nitric oxide storage | 5.972774e-5 |
GO:0060192 | negative regulation of lipase activity | 5.975800e-5 |
GO:0001522 | pseudouridine synthesis | 6.019755e-5 |
GO:0071230 | cellular response to amino acid stimulus | 6.069255e-5 |
GO:0034369 | plasma lipoprotein particle remodeling | 6.160079e-5 |
GO:0006646 | phosphatidylethanolamine biosynthetic process | 6.325947e-5 |
GO:0006022 | aminoglycan metabolic process | 6.422973e-5 |
GO:0030157 | pancreatic juice secretion | 6.684622e-5 |
GO:0045046 | protein import into peroxisome membrane | 7.067937e-5 |
GO:0042157 | lipoprotein metabolic process | 9.081729e-5 |
GO:0051085 | chaperone mediated protein folding requiring cofactor | 9.228684e-5 |
GO:0007195 | inhibition of adenylate cyclase activity by dopamine receptor signaling pathway | 9.240152e-5 |
GO:0010985 | negative regulation of lipoprotein particle clearance | 9.443022e-5 |
GO:0070574 | cadmium ion transmembrane transport | 9.701166e-5 |
GO:0051084 | 'de novo' posttranslational protein folding | 9.936568e-5 |
GO:0030719 | P granule organization | 9.971851e-5 |
GO:0046426 | negative regulation of JAK-STAT cascade | 1.002226e-4 |
GO:0045988 | negative regulation of striated muscle contraction | 1.002226e-4 |
GO:0010735 | positive regulation of transcription via serum response element binding | 1.026352e-4 |
GO:0030262 | apoptotic nuclear change | 1.041813e-4 |
GO:0000303 | response to superoxide | 1.085172e-4 |
GO:0042532 | negative regulation of tyrosine phosphorylation of STAT protein | 1.087272e-4 |
GO:0044236 | multicellular organismal metabolic process | 1.105812e-4 |
GO:0042048 | olfactory behavior | 1.113680e-4 |
GO:0060611 | mammary gland fat development | 1.146904e-4 |
GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin | 1.186602e-4 |
GO:0006400 | tRNA modification | 1.199092e-4 |
GO:0034377 | plasma lipoprotein particle assembly | 1.218344e-4 |
GO:0002577 | regulation of antigen processing and presentation | 1.225454e-4 |
GO:0008610 | lipid biosynthetic process | 1.231723e-4 |
GO:0051289 | protein homotetramerization | 1.249118e-4 |
GO:0042488 | positive regulation of odontogenesis of dentine-containing tooth | 1.325223e-4 |
GO:0007509 | mesoderm migration involved in gastrulation | 1.351068e-4 |
GO:0032963 | collagen metabolic process | 1.354864e-4 |
GO:0060419 | heart growth | 1.420136e-4 |
GO:0019430 | removal of superoxide radicals | 1.420877e-4 |
GO:0015670 | carbon dioxide transport | 1.422873e-4 |
GO:0006399 | tRNA metabolic process | 1.462308e-4 |
GO:0035799 | ureter maturation | 1.482050e-4 |
GO:2000597 | positive regulation of optic nerve formation | 1.482050e-4 |
GO:0061360 | optic chiasma development | 1.482050e-4 |
GO:0021650 | vestibulocochlear nerve formation | 1.482050e-4 |
GO:0021633 | optic nerve structural organization | 1.482050e-4 |
GO:0031081 | nuclear pore distribution | 1.497100e-4 |
GO:0010901 | regulation of very-low-density lipoprotein particle remodeling | 1.503937e-4 |
GO:0007021 | tubulin complex assembly | 1.523265e-4 |
GO:0002017 | regulation of blood volume by renal aldosterone | 1.548127e-4 |
GO:0001840 | neural plate development | 1.548725e-4 |
GO:0006986 | response to unfolded protein | 1.644027e-4 |
GO:0045112 | integrin biosynthetic process | 1.657968e-4 |
GO:0045109 | intermediate filament organization | 1.659142e-4 |
GO:0009262 | deoxyribonucleotide metabolic process | 1.684651e-4 |
GO:0010544 | negative regulation of platelet activation | 1.696549e-4 |
GO:0006285 | base-excision repair, AP site formation | 1.732069e-4 |
GO:0070228 | regulation of lymphocyte apoptosis | 1.747154e-4 |
GO:0007141 | male meiosis I | 1.750459e-4 |
GO:0007398 | ectoderm development | 1.791341e-4 |
GO:0036006 | cellular response to macrophage colony-stimulating factor stimulus | 1.803810e-4 |
GO:0002902 | regulation of B cell apoptosis | 1.810298e-4 |
GO:0032088 | negative regulation of NF-kappaB transcription factor activity | 1.822475e-4 |
GO:0045618 | positive regulation of keratinocyte differentiation | 1.932363e-4 |
GO:0043588 | skin development | 1.940970e-4 |
GO:0006625 | protein targeting to peroxisome | 1.952597e-4 |
GO:0070375 | BMK cascade | 2.028249e-4 |
GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing | 2.041008e-4 |
GO:0044259 | multicellular organismal macromolecule metabolic process | 2.060599e-4 |
GO:0045918 | negative regulation of cytolysis | 2.067620e-4 |
GO:0019264 | glycine biosynthetic process from serine | 2.067620e-4 |
GO:0009225 | nucleotide-sugar metabolic process | 2.090153e-4 |
GO:0060346 | bone trabecula formation | 2.090153e-4 |
GO:0007635 | chemosensory behavior | 2.147432e-4 |
GO:0000305 | response to oxygen radical | 2.155369e-4 |
GO:0031440 | regulation of mRNA 3'-end processing | 2.202578e-4 |
GO:0045746 | negative regulation of Notch signaling pathway | 2.210716e-4 |
GO:0033625 | positive regulation of integrin activation | 2.244715e-4 |
GO:0071385 | cellular response to glucocorticoid stimulus | 2.259450e-4 |
GO:0031670 | cellular response to nutrient | 2.264840e-4 |
GO:0071229 | cellular response to acid | 2.450053e-4 |
GO:0008202 | steroid metabolic process | 2.505554e-4 |
GO:0051293 | establishment of spindle localization | 2.595982e-4 |
GO:0060482 | lobar bronchus development | 2.631993e-4 |
GO:0016052 | carbohydrate catabolic process | 2.657755e-4 |
GO:0006855 | drug transmembrane transport | 2.737152e-4 |
GO:0001957 | intramembranous ossification | 2.829969e-4 |
GO:0048627 | myoblast development | 2.929411e-4 |
GO:0046069 | cGMP catabolic process | 2.966010e-4 |
GO:0034614 | cellular response to reactive oxygen species | 3.017904e-4 |
GO:0061025 | membrane fusion | 3.156908e-4 |
GO:0045651 | positive regulation of macrophage differentiation | 3.249312e-4 |
GO:0045657 | positive regulation of monocyte differentiation | 3.249312e-4 |
GO:0072040 | negative regulation of mesenchymal stem cell apoptosis involved in nephron morphogenesis | 3.268654e-4 |
GO:0045454 | cell redox homeostasis | 3.486940e-4 |
GO:0005976 | polysaccharide metabolic process | 3.507887e-4 |
GO:0006853 | carnitine shuttle | 3.561831e-4 |
GO:0072593 | reactive oxygen species metabolic process | 3.610075e-4 |
GO:0006308 | DNA catabolic process | 3.638757e-4 |
GO:0045655 | regulation of monocyte differentiation | 3.653964e-4 |
GO:0006942 | regulation of striated muscle contraction | 3.723218e-4 |
GO:0051262 | protein tetramerization | 3.728272e-4 |
GO:0006560 | proline metabolic process | 3.745420e-4 |
GO:0006944 | cellular membrane fusion | 3.764082e-4 |
GO:0045007 | depurination | 3.770136e-4 |
GO:0097006 | regulation of plasma lipoprotein particle levels | 3.787103e-4 |
GO:0043574 | peroxisomal transport | 3.877693e-4 |
GO:0014873 | response to muscle activity involved in regulation of muscle adaptation | 3.936175e-4 |
GO:0061049 | cell growth involved in cardiac muscle cell development | 3.936175e-4 |
GO:0003331 | positive regulation of extracellular matrix constituent secretion | 3.936175e-4 |
GO:0002508 | central tolerance induction | 3.936175e-4 |
GO:0001998 | angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure | 3.936175e-4 |
GO:0002897 | positive regulation of central B cell tolerance induction | 3.936175e-4 |
GO:0046394 | carboxylic acid biosynthetic process | 3.960515e-4 |
GO:0042512 | negative regulation of tyrosine phosphorylation of Stat1 protein | 3.971844e-4 |
GO:0034374 | low-density lipoprotein particle remodeling | 4.016377e-4 |
GO:0002115 | store-operated calcium entry | 4.122068e-4 |
GO:2000242 | negative regulation of reproductive process | 4.134063e-4 |
GO:0006458 | 'de novo' protein folding | 4.152567e-4 |
GO:0003057 | regulation of the force of heart contraction by chemical signal | 4.171953e-4 |
GO:0006438 | valyl-tRNA aminoacylation | 4.220439e-4 |
GO:0010596 | negative regulation of endothelial cell migration | 4.340394e-4 |
GO:0048664 | neuron fate determination | 4.393828e-4 |
GO:0043060 | meiotic metaphase I plate congression | 4.449969e-4 |
GO:0010903 | negative regulation of very-low-density lipoprotein particle remodeling | 4.493586e-4 |
GO:2000106 | regulation of leukocyte apoptosis | 4.563856e-4 |
GO:0090257 | regulation of muscle system process | 4.655025e-4 |
GO:0000272 | polysaccharide catabolic process | 4.730486e-4 |
GO:0021575 | hindbrain morphogenesis | 4.751112e-4 |
GO:0014014 | negative regulation of gliogenesis | 4.782484e-4 |
GO:0016126 | sterol biosynthetic process | 4.830175e-4 |
GO:0021998 | neural plate mediolateral regionalization | 5.005590e-4 |
GO:0048352 | paraxial mesoderm structural organization | 5.005590e-4 |
GO:0042723 | thiamine-containing compound metabolic process | 5.110021e-4 |
GO:0006949 | syncytium formation | 5.114390e-4 |
GO:0021555 | midbrain-hindbrain boundary morphogenesis | 5.145580e-4 |
GO:0031119 | tRNA pseudouridine synthesis | 5.190550e-4 |
GO:0018009 | N-terminal peptidyl-L-cysteine N-palmitoylation | 5.190550e-4 |
GO:0051567 | histone H3-K9 methylation | 5.198488e-4 |
GO:0001880 | Mullerian duct regression | 5.415658e-4 |
GO:0033159 | negative regulation of protein import into nucleus, translocation | 5.415658e-4 |
GO:0042703 | menstruation | 5.434190e-4 |
GO:0019101 | female somatic sex determination | 5.434190e-4 |
GO:0003406 | retinal pigment epithelium development | 5.434190e-4 |
GO:0070344 | regulation of fat cell proliferation | 5.562538e-4 |
GO:0015695 | organic cation transport | 5.762844e-4 |
GO:0051346 | negative regulation of hydrolase activity | 5.779964e-4 |
GO:0021903 | rostrocaudal neural tube patterning | 5.877411e-4 |
GO:0032506 | cytokinetic process | 5.905039e-4 |
GO:0044154 | histone H3-K14 acetylation | 5.929726e-4 |
GO:0035511 | oxidative DNA demethylation | 5.941859e-4 |
GO:0001977 | renal system process involved in regulation of blood volume | 5.993623e-4 |
GO:0045047 | protein targeting to ER | 6.043980e-4 |
GO:0070734 | histone H3-K27 methylation | 6.070298e-4 |
GO:0048382 | mesendoderm development | 6.070298e-4 |
GO:0055017 | cardiac muscle tissue growth | 6.210717e-4 |
GO:0097150 | neuronal stem cell maintenance | 6.232503e-4 |
GO:0001955 | blood vessel maturation | 6.272815e-4 |
GO:0051303 | establishment of chromosome localization | 6.285458e-4 |
GO:0010960 | magnesium ion homeostasis | 6.439570e-4 |
GO:0009069 | serine family amino acid metabolic process | 6.468985e-4 |
GO:0031268 | pseudopodium organization | 6.610955e-4 |
GO:0021528 | commissural neuron differentiation in spinal cord | 6.610955e-4 |
GO:0032355 | response to estradiol stimulus | 6.621964e-4 |
GO:0042168 | heme metabolic process | 6.890404e-4 |
GO:0071356 | cellular response to tumor necrosis factor | 6.952342e-4 |
GO:0006065 | UDP-glucuronate biosynthetic process | 6.955481e-4 |
GO:2000974 | negative regulation of pro-B cell differentiation | 6.960414e-4 |
GO:0016480 | negative regulation of transcription from RNA polymerase III promoter | 7.260124e-4 |
GO:0003105 | negative regulation of glomerular filtration | 7.783522e-4 |
GO:0000093 | mitotic telophase | 7.934392e-4 |
GO:0006551 | leucine metabolic process | 8.208524e-4 |
GO:0010721 | negative regulation of cell development | 8.323305e-4 |
GO:0006633 | fatty acid biosynthetic process | 8.331074e-4 |
GO:0014908 | myotube differentiation involved in skeletal muscle regeneration | 8.409956e-4 |
GO:0023035 | CD40 signaling pathway | 8.409956e-4 |
GO:0008049 | male courtship behavior | 8.409956e-4 |
GO:0022007 | convergent extension involved in neural plate elongation | 8.573714e-4 |
GO:0071383 | cellular response to steroid hormone stimulus | 8.656797e-4 |
GO:0046340 | diacylglycerol catabolic process | 8.696041e-4 |
GO:0097039 | protein linear polyubiquitination | 8.699855e-4 |
GO:0070849 | response to epidermal growth factor stimulus | 8.768672e-4 |
GO:0002830 | positive regulation of type 2 immune response | 8.769142e-4 |
GO:0000271 | polysaccharide biosynthetic process | 8.786881e-4 |
GO:0002066 | columnar/cuboidal epithelial cell development | 8.945041e-4 |
GO:2000737 | negative regulation of stem cell differentiation | 8.949470e-4 |
GO:0009303 | rRNA transcription | 9.130450e-4 |
GO:0042661 | regulation of mesodermal cell fate specification | 9.359211e-4 |
GO:0043534 | blood vessel endothelial cell migration | 9.608909e-4 |
GO:0006857 | oligopeptide transport | 9.774151e-4 |
GO:0072108 | positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis | 9.774480e-4 |
GO:0043248 | proteasome assembly | 1.013863e-3 |
GO:0016557 | peroxisome membrane biogenesis | 1.023890e-3 |
GO:0042354 | L-fucose metabolic process | 1.032527e-3 |
GO:0030203 | glycosaminoglycan metabolic process | 1.056209e-3 |
GO:2000210 | positive regulation of anoikis | 1.062033e-3 |
GO:0006561 | proline biosynthetic process | 1.062033e-3 |
GO:2000380 | regulation of mesoderm development | 1.067602e-3 |
GO:0051952 | regulation of amine transport | 1.077066e-3 |
GO:0071460 | cellular response to cell-matrix adhesion | 1.099602e-3 |
GO:0071335 | hair follicle cell proliferation | 1.117937e-3 |
GO:0032290 | peripheral nervous system myelin formation | 1.117937e-3 |
GO:0043128 | positive regulation of 1-phosphatidylinositol 4-kinase activity | 1.144135e-3 |
GO:0045799 | positive regulation of chromatin assembly or disassembly | 1.155344e-3 |
GO:0035845 | photoreceptor cell outer segment organization | 1.155344e-3 |
GO:0035545 | determination of left/right asymmetry in nervous system | 1.155344e-3 |
GO:0032902 | nerve growth factor production | 1.200581e-3 |
GO:0032057 | negative regulation of translational initiation in response to stress | 1.204041e-3 |
GO:0035814 | negative regulation of renal sodium excretion | 1.206410e-3 |
GO:0051220 | cytoplasmic sequestering of protein | 1.236330e-3 |
GO:0014037 | Schwann cell differentiation | 1.236330e-3 |
GO:0030225 | macrophage differentiation | 1.246152e-3 |
GO:0035090 | maintenance of apical/basal cell polarity | 1.251668e-3 |
GO:0021587 | cerebellum morphogenesis | 1.254616e-3 |
GO:0032606 | type I interferon production | 1.258486e-3 |
GO:0030185 | nitric oxide transport | 1.262168e-3 |
GO:0007162 | negative regulation of cell adhesion | 1.267079e-3 |
GO:0030004 | cellular monovalent inorganic cation homeostasis | 1.270902e-3 |
GO:0006370 | mRNA capping | 1.276158e-3 |
GO:0009308 | amine metabolic process | 1.286152e-3 |
GO:0007128 | meiotic prophase I | 1.310527e-3 |
GO:0046339 | diacylglycerol metabolic process | 1.331876e-3 |
GO:0048144 | fibroblast proliferation | 1.358838e-3 |
GO:0001516 | prostaglandin biosynthetic process | 1.384183e-3 |
GO:0006636 | unsaturated fatty acid biosynthetic process | 1.418325e-3 |
GO:0008078 | mesodermal cell migration | 1.464266e-3 |
GO:0001990 | regulation of systemic arterial blood pressure by hormone | 1.499425e-3 |
GO:0007217 | tachykinin receptor signaling pathway | 1.524429e-3 |
GO:0009452 | RNA capping | 1.527889e-3 |
GO:0042074 | cell migration involved in gastrulation | 1.560099e-3 |
GO:0000726 | non-recombinational repair | 1.568471e-3 |
GO:0009589 | detection of UV | 1.581168e-3 |
GO:0010999 | regulation of eIF2 alpha phosphorylation by heme | 1.581168e-3 |
GO:0002554 | serotonin secretion by platelet | 1.581168e-3 |
GO:0002522 | leukocyte migration involved in immune response | 1.581168e-3 |
GO:0050771 | negative regulation of axonogenesis | 1.590325e-3 |
GO:0070926 | regulation of ATP:ADP antiporter activity | 1.604233e-3 |
GO:0008065 | establishment of blood-nerve barrier | 1.604233e-3 |
GO:0002071 | glandular epithelial cell maturation | 1.604233e-3 |
GO:0042117 | monocyte activation | 1.605754e-3 |
GO:0031668 | cellular response to extracellular stimulus | 1.609594e-3 |
GO:0007253 | cytoplasmic sequestering of NF-kappaB | 1.624180e-3 |
GO:0031282 | regulation of guanylate cyclase activity | 1.648975e-3 |
GO:0046877 | regulation of saliva secretion | 1.648975e-3 |
GO:0050779 | RNA destabilization | 1.660105e-3 |
GO:0009103 | lipopolysaccharide biosynthetic process | 1.664602e-3 |
GO:0002676 | regulation of chronic inflammatory response | 1.664602e-3 |
GO:0006481 | C-terminal protein methylation | 1.664677e-3 |
GO:0051764 | actin crosslink formation | 1.688588e-3 |
GO:0042159 | lipoprotein catabolic process | 1.700353e-3 |
GO:0045919 | positive regulation of cytolysis | 1.708145e-3 |
GO:0042552 | myelination | 1.729805e-3 |
GO:0045110 | intermediate filament bundle assembly | 1.739850e-3 |
GO:0060179 | male mating behavior | 1.747488e-3 |
GO:0045199 | maintenance of epithelial cell apical/basal polarity | 1.747488e-3 |
GO:0010939 | regulation of necrotic cell death | 1.751455e-3 |
GO:0045342 | MHC class II biosynthetic process | 1.789607e-3 |
GO:0070839 | divalent metal ion export | 1.789607e-3 |
GO:0043091 | L-arginine import | 1.789607e-3 |
GO:0015707 | nitrite transport | 1.789607e-3 |
GO:0006876 | cellular cadmium ion homeostasis | 1.789607e-3 |
GO:0032632 | interleukin-3 production | 1.789607e-3 |
GO:0035767 | endothelial cell chemotaxis | 1.794847e-3 |
GO:0051588 | regulation of neurotransmitter transport | 1.806239e-3 |
GO:0070988 | demethylation | 1.811343e-3 |
GO:0007031 | peroxisome organization | 1.865042e-3 |
GO:0072668 | tubulin complex biogenesis | 1.869038e-3 |
GO:0072321 | chaperone-mediated protein transport | 1.875118e-3 |
GO:0060282 | positive regulation of oocyte development | 1.883974e-3 |
GO:0009071 | serine family amino acid catabolic process | 1.945556e-3 |
GO:0000387 | spliceosomal snRNP assembly | 1.949131e-3 |
GO:0008355 | olfactory learning | 1.968472e-3 |
GO:0002443 | leukocyte mediated immunity | 1.970090e-3 |
GO:0034384 | high-density lipoprotein particle clearance | 1.988152e-3 |
GO:0048477 | oogenesis | 1.992645e-3 |
GO:0035089 | establishment of apical/basal cell polarity | 1.994283e-3 |
GO:0050832 | defense response to fungus | 2.001048e-3 |
GO:0000002 | mitochondrial genome maintenance | 2.013957e-3 |
GO:0060555 | induction of necroptosis by extracellular signals | 2.015548e-3 |
GO:0006546 | glycine catabolic process | 2.038607e-3 |
GO:0006091 | generation of precursor metabolites and energy | 2.052700e-3 |
GO:0006066 | alcohol metabolic process | 2.058725e-3 |
GO:0023019 | signal transduction involved in regulation of gene expression | 2.063181e-3 |
GO:0034104 | negative regulation of tissue remodeling | 2.108404e-3 |
GO:0046185 | aldehyde catabolic process | 2.122319e-3 |
GO:0060911 | cardiac cell fate commitment | 2.131398e-3 |
GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I | 2.163164e-3 |
GO:0055010 | ventricular cardiac muscle tissue morphogenesis | 2.201110e-3 |
GO:0070417 | cellular response to cold | 2.204177e-3 |
GO:0044283 | small molecule biosynthetic process | 2.211082e-3 |
GO:0001958 | endochondral ossification | 2.224115e-3 |
GO:0060920 | pacemaker cell differentiation | 2.240543e-3 |
GO:0030221 | basophil differentiation | 2.240543e-3 |
GO:0010897 | negative regulation of triglyceride catabolic process | 2.240543e-3 |
GO:0030213 | hyaluronan biosynthetic process | 2.240543e-3 |
GO:0010987 | negative regulation of high-density lipoprotein particle clearance | 2.240543e-3 |
GO:0060691 | epithelial cell maturation involved in salivary gland development | 2.297934e-3 |
GO:0060096 | serotonin secretion, neurotransmission | 2.297934e-3 |
GO:0000239 | pachytene | 2.317486e-3 |
GO:0051532 | regulation of NFAT protein import into nucleus | 2.325498e-3 |
GO:0045606 | positive regulation of epidermal cell differentiation | 2.351580e-3 |
GO:0010830 | regulation of myotube differentiation | 2.376415e-3 |
GO:0060060 | post-embryonic retina morphogenesis in camera-type eye | 2.427260e-3 |
GO:0007518 | myoblast cell fate determination | 2.427260e-3 |
GO:0030037 | actin filament reorganization involved in cell cycle | 2.429984e-3 |
GO:0002460 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 2.509770e-3 |
GO:0048242 | epinephrine secretion | 2.540764e-3 |
GO:0072205 | metanephric collecting duct development | 2.543204e-3 |
GO:0055067 | monovalent inorganic cation homeostasis | 2.548405e-3 |
GO:0050433 | regulation of catecholamine secretion | 2.556745e-3 |
GO:0046878 | positive regulation of saliva secretion | 2.568747e-3 |
GO:0002074 | extraocular skeletal muscle development | 2.568747e-3 |
GO:0061009 | common bile duct development | 2.569431e-3 |
GO:0006307 | DNA dealkylation involved in DNA repair | 2.569431e-3 |
GO:0035566 | regulation of metanephros size | 2.599968e-3 |
GO:0016081 | synaptic vesicle docking involved in exocytosis | 2.604458e-3 |
GO:0070305 | response to cGMP | 2.604709e-3 |
GO:0007589 | body fluid secretion | 2.626294e-3 |
GO:0030220 | platelet formation | 2.634481e-3 |
GO:0006457 | protein folding | 2.639618e-3 |
GO:0006892 | post-Golgi vesicle-mediated transport | 2.646971e-3 |
GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase | 2.687073e-3 |
GO:0008594 | photoreceptor cell morphogenesis | 2.702999e-3 |
GO:0042304 | regulation of fatty acid biosynthetic process | 2.740669e-3 |
GO:0043589 | skin morphogenesis | 2.742187e-3 |
GO:0035036 | sperm-egg recognition | 2.747146e-3 |
GO:0048147 | negative regulation of fibroblast proliferation | 2.818361e-3 |
GO:0018146 | keratan sulfate biosynthetic process | 2.819672e-3 |
GO:0015893 | drug transport | 2.822096e-3 |
GO:0042593 | glucose homeostasis | 2.848013e-3 |
GO:0006023 | aminoglycan biosynthetic process | 2.848274e-3 |
GO:0071321 | cellular response to cGMP | 2.848685e-3 |
GO:0071585 | detoxification of cadmium ion | 2.866484e-3 |
GO:0034224 | cellular response to zinc ion starvation | 2.866484e-3 |
GO:0034120 | positive regulation of erythrocyte aggregation | 2.866484e-3 |
GO:0048378 | regulation of lateral mesodermal cell fate specification | 2.979965e-3 |
GO:0006011 | UDP-glucose metabolic process | 2.979965e-3 |
GO:0014029 | neural crest formation | 2.998944e-3 |
GO:0006657 | CDP-choline pathway | 3.009293e-3 |
GO:0001707 | mesoderm formation | 3.018267e-3 |
GO:0042891 | antibiotic transport | 3.018761e-3 |
GREAT analysis results for mouseGenomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon <br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0003158 | endothelium development | 1.458311e-9 |
GO:0045446 | endothelial cell differentiation | 2.115551e-9 |
GO:0035966 | response to topologically incorrect protein | 1.125364e-8 |
GO:0045796 | negative regulation of intestinal cholesterol absorption | 3.214874e-8 |
GO:0010949 | negative regulation of intestinal phytosterol absorption | 3.214874e-8 |
GO:0045920 | negative regulation of exocytosis | 4.049091e-8 |
GO:0035691 | macrophage migration inhibitory factor signaling pathway | 4.738862e-8 |
GO:0001885 | endothelial cell development | 7.608635e-8 |
GO:0051085 | chaperone mediated protein folding requiring cofactor | 8.199762e-8 |
GO:0061077 | chaperone-mediated protein folding | 1.939151e-7 |
GO:0045578 | negative regulation of B cell differentiation | 2.259766e-7 |
GO:0046325 | negative regulation of glucose import | 2.489167e-7 |
GO:0010829 | negative regulation of glucose transport | 3.301759e-7 |
GO:0032456 | endocytic recycling | 5.473981e-7 |
GO:0044062 | regulation of excretion | 7.585927e-7 |
GO:2000079 | regulation of canonical Wnt receptor signaling pathway involved in controlling type B pancreatic cell proliferation | 8.686097e-7 |
GO:0035813 | regulation of renal sodium excretion | 9.158583e-7 |
GO:0060457 | negative regulation of digestive system process | 9.309721e-7 |
GO:0018209 | peptidyl-serine modification | 1.154266e-6 |
GO:0006986 | response to unfolded protein | 1.515029e-6 |
GO:0051084 | 'de novo' posttranslational protein folding | 1.941529e-6 |
GO:2000054 | negative regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification | 1.943610e-6 |
GO:0051532 | regulation of NFAT protein import into nucleus | 2.121708e-6 |
GO:0035967 | cellular response to topologically incorrect protein | 2.132495e-6 |
GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II | 2.520392e-6 |
GO:2000271 | positive regulation of fibroblast apoptosis | 2.936083e-6 |
GO:0030042 | actin filament depolymerization | 2.936083e-6 |
GO:2000270 | negative regulation of fibroblast apoptosis | 2.936083e-6 |
GO:0044345 | stromal-epithelial cell signaling involved in prostate gland development | 2.936083e-6 |
GO:2000080 | negative regulation of canonical Wnt receptor signaling pathway involved in controlling type B pancreatic cell proliferation | 2.936083e-6 |
GO:0043301 | negative regulation of leukocyte degranulation | 3.096223e-6 |
GO:0018009 | N-terminal peptidyl-L-cysteine N-palmitoylation | 3.160719e-6 |
GO:0016090 | prenol metabolic process | 3.327350e-6 |
GO:0042274 | ribosomal small subunit biogenesis | 3.431704e-6 |
GO:0034968 | histone lysine methylation | 4.367304e-6 |
GO:0045955 | negative regulation of calcium ion-dependent exocytosis | 4.686860e-6 |
GO:0035814 | negative regulation of renal sodium excretion | 5.266209e-6 |
GO:0045606 | positive regulation of epidermal cell differentiation | 5.881440e-6 |
GO:0045618 | positive regulation of keratinocyte differentiation | 6.270077e-6 |
GO:0060327 | cytoplasmic actin-based contraction involved in cell motility | 6.617064e-6 |
GO:2000392 | regulation of lamellipodium morphogenesis | 6.617064e-6 |
GO:0046949 | fatty-acyl-CoA biosynthetic process | 6.617064e-6 |
GO:0051048 | negative regulation of secretion | 6.913987e-6 |
GO:0061028 | establishment of endothelial barrier | 7.099020e-6 |
GO:0022009 | central nervous system vasculogenesis | 7.331569e-6 |
GO:0032682 | negative regulation of chemokine production | 7.763867e-6 |
GO:0051261 | protein depolymerization | 8.005286e-6 |
GO:0042790 | transcription of nuclear large rRNA transcript from RNA polymerase I promoter | 8.334707e-6 |
GO:0018105 | peptidyl-serine phosphorylation | 9.101607e-6 |
GO:0048384 | retinoic acid receptor signaling pathway | 9.109008e-6 |
GO:0071380 | cellular response to prostaglandin E stimulus | 9.655370e-6 |
GO:0016571 | histone methylation | 1.031815e-5 |
GO:0045684 | positive regulation of epidermis development | 1.097549e-5 |
GO:0071218 | cellular response to misfolded protein | 1.106215e-5 |
GO:0051533 | positive regulation of NFAT protein import into nucleus | 1.106215e-5 |
GO:0018022 | peptidyl-lysine methylation | 1.152123e-5 |
GO:0072061 | inner medullary collecting duct development | 1.207600e-5 |
GO:0016332 | establishment or maintenance of polarity of embryonic epithelium | 1.207600e-5 |
GO:0072060 | outer medullary collecting duct development | 1.207600e-5 |
GO:0002268 | follicular dendritic cell differentiation | 1.481331e-5 |
GO:0018023 | peptidyl-lysine trimethylation | 1.520771e-5 |
GO:0072364 | regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter | 1.697968e-5 |
GO:0030490 | maturation of SSU-rRNA | 1.726240e-5 |
GO:0090023 | positive regulation of neutrophil chemotaxis | 1.952022e-5 |
GO:0051051 | negative regulation of transport | 2.001107e-5 |
GO:0060461 | right lung morphogenesis | 2.464356e-5 |
GO:0090131 | mesenchyme migration | 2.464356e-5 |
GO:0060446 | branching involved in open tracheal system development | 2.464356e-5 |
GO:0048371 | lateral mesodermal cell differentiation | 2.464356e-5 |
GO:0048613 | embryonic ectodermal digestive tract morphogenesis | 2.464356e-5 |
GO:0014822 | detection of wounding | 2.464356e-5 |
GO:0060482 | lobar bronchus development | 2.515513e-5 |
GO:0006360 | transcription from RNA polymerase I promoter | 3.179229e-5 |
GO:0031999 | negative regulation of fatty acid beta-oxidation | 3.260172e-5 |
GO:2000343 | positive regulation of chemokine (C-X-C motif) ligand 2 production | 3.534583e-5 |
GO:0048566 | embryonic digestive tract development | 3.738601e-5 |
GO:0061038 | uterus morphogenesis | 3.864734e-5 |
GO:0043314 | negative regulation of neutrophil degranulation | 4.024759e-5 |
GO:0060218 | hemopoietic stem cell differentiation | 4.024759e-5 |
GO:0060669 | embryonic placenta morphogenesis | 4.236451e-5 |
GO:0016082 | synaptic vesicle priming | 4.862195e-5 |
GO:0060708 | spongiotrophoblast differentiation | 4.935397e-5 |
GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development | 5.031059e-5 |
GO:0051014 | actin filament severing | 5.031059e-5 |
GO:0045575 | basophil activation | 5.273955e-5 |
GO:0034651 | cortisol biosynthetic process | 5.273955e-5 |
GO:0035865 | cellular response to potassium ion | 5.273955e-5 |
GO:0035659 | Wnt receptor signaling pathway involved in wound healing, spreading of epidermal cells | 5.302869e-5 |
GO:0014719 | satellite cell activation | 5.302869e-5 |
GO:0072044 | collecting duct development | 5.455766e-5 |
GO:0032692 | negative regulation of interleukin-1 production | 5.539595e-5 |
GO:0060555 | induction of necroptosis by extracellular signals | 5.706736e-5 |
GO:0032930 | positive regulation of superoxide anion generation | 5.706736e-5 |
GO:0032928 | regulation of superoxide anion generation | 5.958902e-5 |
GO:0060712 | spongiotrophoblast layer development | 6.432473e-5 |
GO:0072095 | regulation of branch elongation involved in ureteric bud branching | 6.764939e-5 |
GO:0017158 | regulation of calcium ion-dependent exocytosis | 6.815505e-5 |
GO:0016074 | snoRNA metabolic process | 6.911624e-5 |
GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing | 7.633631e-5 |
GO:0035269 | protein O-linked mannosylation | 8.013832e-5 |
GO:0002328 | pro-B cell differentiation | 9.031908e-5 |
GO:0044058 | regulation of digestive system process | 1.010859e-4 |
GO:0060709 | glycogen cell development involved in embryonic placenta development | 1.042066e-4 |
GO:0032342 | aldosterone biosynthetic process | 1.042066e-4 |
GO:0072181 | mesonephric duct formation | 1.128523e-4 |
GO:0001555 | oocyte growth | 1.128523e-4 |
GO:0072172 | mesonephric tubule formation | 1.162256e-4 |
GO:0071299 | cellular response to vitamin A | 1.177018e-4 |
GO:0002036 | regulation of L-glutamate transport | 1.240670e-4 |
GO:0002606 | positive regulation of dendritic cell antigen processing and presentation | 1.260808e-4 |
GO:0014045 | establishment of endothelial blood-brain barrier | 1.260808e-4 |
GO:0006515 | misfolded or incompletely synthesized protein catabolic process | 1.451942e-4 |
GO:0045948 | positive regulation of translational initiation | 1.462372e-4 |
GO:0032691 | negative regulation of interleukin-1 beta production | 1.552515e-4 |
GO:0017157 | regulation of exocytosis | 1.606210e-4 |
GO:0006546 | glycine catabolic process | 1.618550e-4 |
GO:0006417 | regulation of translation | 1.636008e-4 |
GO:0023019 | signal transduction involved in regulation of gene expression | 1.694969e-4 |
GO:0072205 | metanephric collecting duct development | 1.701842e-4 |
GO:0071773 | cellular response to BMP stimulus | 1.897949e-4 |
GO:0045835 | negative regulation of meiosis | 1.897949e-4 |
GO:0009956 | radial pattern formation | 1.897949e-4 |
GO:2000429 | negative regulation of neutrophil aggregation | 2.154242e-4 |
GO:2000469 | negative regulation of peroxidase activity | 2.154242e-4 |
GO:0071638 | negative regulation of monocyte chemotactic protein-1 production | 2.154242e-4 |
GO:0035726 | common myeloid progenitor cell proliferation | 2.154242e-4 |
GO:0002561 | basophil degranulation | 2.154242e-4 |
GO:0021528 | commissural neuron differentiation in spinal cord | 2.154242e-4 |
GO:0048227 | plasma membrane to endosome transport | 2.154242e-4 |
GO:0002830 | positive regulation of type 2 immune response | 2.174301e-4 |
GO:0071300 | cellular response to retinoic acid | 2.230622e-4 |
GO:0032536 | regulation of cell projection size | 2.305453e-4 |
GO:0090022 | regulation of neutrophil chemotaxis | 2.426169e-4 |
GO:0006927 | transformed cell apoptosis | 2.438103e-4 |
GO:0035729 | cellular response to hepatocyte growth factor stimulus | 2.841600e-4 |
GO:0016064 | immunoglobulin mediated immune response | 2.918677e-4 |
GO:0035565 | regulation of pronephros size | 2.974175e-4 |
GO:0039020 | pronephric nephron tubule development | 2.974175e-4 |
GO:0003329 | pancreatic PP cell fate commitment | 2.974175e-4 |
GO:0003326 | pancreatic A cell fate commitment | 2.974175e-4 |
GO:0055123 | digestive system development | 2.999327e-4 |
GO:0018192 | enzyme active site formation via L-cysteine persulfide | 3.303867e-4 |
GO:0001552 | ovarian follicle atresia | 3.315380e-4 |
GO:0019428 | allantoin biosynthetic process | 3.315380e-4 |
GO:0006098 | pentose-phosphate shunt | 3.463664e-4 |
GO:0071845 | cellular component disassembly at cellular level | 3.521273e-4 |
GO:0019724 | B cell mediated immunity | 3.523989e-4 |
GO:0010939 | regulation of necrotic cell death | 3.545735e-4 |
GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II | 3.785817e-4 |
GO:0002504 | antigen processing and presentation of peptide or polysaccharide antigen via MHC class II | 3.815591e-4 |
GO:0048388 | endosomal lumen acidification | 3.857252e-4 |
GO:0007163 | establishment or maintenance of cell polarity | 3.913039e-4 |
GO:0002858 | regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 4.039057e-4 |
GO:0060430 | lung saccule development | 4.065377e-4 |
GO:0072164 | mesonephric tubule development | 4.102228e-4 |
GO:0001823 | mesonephros development | 4.114869e-4 |
GO:0021893 | cerebral cortex GABAergic interneuron fate commitment | 4.151251e-4 |
GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment | 4.151251e-4 |
GO:2000053 | regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification | 4.155007e-4 |
GO:0007028 | cytoplasm organization | 4.155007e-4 |
GO:0018216 | peptidyl-arginine methylation | 4.231833e-4 |
GO:0045006 | DNA deamination | 4.271419e-4 |
GO:0018195 | peptidyl-arginine modification | 4.378296e-4 |
GO:0060428 | lung epithelium development | 4.612225e-4 |
GO:0060993 | kidney morphogenesis | 5.001552e-4 |
GO:0034380 | high-density lipoprotein particle assembly | 5.105185e-4 |
GO:0002642 | positive regulation of immunoglobulin biosynthetic process | 5.150247e-4 |
GO:0019348 | dolichol metabolic process | 5.310272e-4 |
GO:2000117 | negative regulation of cysteine-type endopeptidase activity | 5.310272e-4 |
GO:0002860 | positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 5.413810e-4 |
GO:0070141 | response to UV-A | 5.522912e-4 |
GO:0018198 | peptidyl-cysteine modification | 5.522912e-4 |
GO:0001893 | maternal placenta development | 5.558501e-4 |
GO:0032770 | positive regulation of monooxygenase activity | 5.560228e-4 |
GO:0031133 | regulation of axon diameter | 5.684507e-4 |
GO:0035246 | peptidyl-arginine N-methylation | 5.729679e-4 |
GO:0007029 | endoplasmic reticulum organization | 5.779077e-4 |
GO:0022411 | cellular component disassembly | 6.003682e-4 |
GO:0014807 | regulation of somitogenesis | 6.392196e-4 |
GO:0003270 | Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation | 6.392196e-4 |
GO:0051788 | response to misfolded protein | 6.663603e-4 |
GO:0051044 | positive regulation of membrane protein ectodomain proteolysis | 6.663603e-4 |
GO:0030968 | endoplasmic reticulum unfolded protein response | 6.674291e-4 |
GO:2000146 | negative regulation of cell motility | 6.792597e-4 |
GO:0032488 | Cdc42 protein signal transduction | 6.871390e-4 |
GO:0019673 | GDP-mannose metabolic process | 7.361381e-4 |
GO:0002443 | leukocyte mediated immunity | 7.364778e-4 |
GO:0030336 | negative regulation of cell migration | 7.472733e-4 |
GO:0003310 | pancreatic A cell differentiation | 7.611581e-4 |
GO:2000052 | positive regulation of non-canonical Wnt receptor signaling pathway | 7.628970e-4 |
GO:0061048 | negative regulation of branching involved in lung morphogenesis | 7.641493e-4 |
GO:0045994 | positive regulation of translational initiation by iron | 7.641493e-4 |
GO:0002037 | negative regulation of L-glutamate transport | 7.641493e-4 |
GO:0034116 | positive regulation of heterotypic cell-cell adhesion | 7.641493e-4 |
GO:0043313 | regulation of neutrophil degranulation | 7.796624e-4 |
GO:0033504 | floor plate development | 8.199701e-4 |
GO:0070303 | negative regulation of stress-activated protein kinase signaling cascade | 8.306494e-4 |
GO:0046185 | aldehyde catabolic process | 8.392919e-4 |
GO:0034637 | cellular carbohydrate biosynthetic process | 8.721668e-4 |
GO:0060010 | Sertoli cell fate commitment | 8.856537e-4 |
GO:0006297 | nucleotide-excision repair, DNA gap filling | 8.856537e-4 |
GO:0030730 | sequestering of triglyceride | 8.901261e-4 |
GO:0006304 | DNA modification | 9.179730e-4 |
GO:0045940 | positive regulation of steroid metabolic process | 9.208687e-4 |
GO:0090136 | epithelial cell-cell adhesion | 9.589388e-4 |
GO:0008625 | induction of apoptosis via death domain receptors | 9.703369e-4 |
GO:0003209 | cardiac atrium morphogenesis | 9.830620e-4 |
GO:0010940 | positive regulation of necrotic cell death | 1.023033e-3 |
GO:0007386 | compartment pattern specification | 1.023033e-3 |
GO:0033566 | gamma-tubulin complex localization | 1.023305e-3 |
GO:0035881 | amacrine cell differentiation | 1.031125e-3 |
GO:0030855 | epithelial cell differentiation | 1.042311e-3 |
GO:0072236 | metanephric loop of Henle development | 1.049131e-3 |
GO:0034969 | histone arginine methylation | 1.057007e-3 |
GO:0050711 | negative regulation of interleukin-1 secretion | 1.061111e-3 |
GO:0019884 | antigen processing and presentation of exogenous antigen | 1.101963e-3 |
GO:0002098 | tRNA wobble uridine modification | 1.138243e-3 |
GO:0051271 | negative regulation of cellular component movement | 1.164935e-3 |
GO:0002478 | antigen processing and presentation of exogenous peptide antigen | 1.167755e-3 |
GO:0032900 | negative regulation of neurotrophin production | 1.173718e-3 |
GO:0032244 | positive regulation of nucleoside transport | 1.173718e-3 |
GO:0072171 | mesonephric tubule morphogenesis | 1.175096e-3 |
GO:0018202 | peptidyl-histidine modification | 1.175096e-3 |
GO:2000781 | positive regulation of double-strand break repair | 1.191532e-3 |
GO:0005979 | regulation of glycogen biosynthetic process | 1.226838e-3 |
GO:0006479 | protein methylation | 1.228914e-3 |
GO:0006796 | phosphate-containing compound metabolic process | 1.256770e-3 |
GO:0070873 | regulation of glycogen metabolic process | 1.336318e-3 |
GO:0071715 | icosanoid transport | 1.349209e-3 |
GO:0003289 | atrial septum primum morphogenesis | 1.349209e-3 |
GO:0006572 | tyrosine catabolic process | 1.365828e-3 |
GO:0003230 | cardiac atrium development | 1.382949e-3 |
GO:0071712 | ER-associated misfolded protein catabolic process | 1.386458e-3 |
GO:0060591 | chondroblast differentiation | 1.405835e-3 |
GO:0034227 | tRNA thio-modification | 1.421291e-3 |
GO:0021915 | neural tube development | 1.459742e-3 |
GO:0046889 | positive regulation of lipid biosynthetic process | 1.517708e-3 |
GO:0046847 | filopodium assembly | 1.524024e-3 |
GO:0014044 | Schwann cell development | 1.544228e-3 |
GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity | 1.573101e-3 |
GO:0045338 | farnesyl diphosphate metabolic process | 1.582359e-3 |
GO:0033159 | negative regulation of protein import into nucleus, translocation | 1.582359e-3 |
GO:0045773 | positive regulation of axon extension | 1.622060e-3 |
GO:0060713 | labyrinthine layer morphogenesis | 1.626411e-3 |
GO:0060033 | anatomical structure regression | 1.635082e-3 |
GO:0045123 | cellular extravasation | 1.636221e-3 |
GO:0006364 | rRNA processing | 1.648657e-3 |
GO:0051568 | histone H3-K4 methylation | 1.683045e-3 |
GO:0045727 | positive regulation of translation | 1.692996e-3 |
GO:0033505 | floor plate morphogenesis | 1.706374e-3 |
GO:0051081 | nuclear envelope disassembly | 1.711855e-3 |
GO:0006560 | proline metabolic process | 1.711855e-3 |
GO:0050901 | leukocyte tethering or rolling | 1.727581e-3 |
GO:0072054 | renal outer medulla development | 1.811579e-3 |
GO:0032615 | interleukin-12 production | 1.811579e-3 |
GO:0030204 | chondroitin sulfate metabolic process | 1.851307e-3 |
GO:0043372 | positive regulation of CD4-positive, alpha-beta T cell differentiation | 1.858104e-3 |
GO:0007440 | foregut morphogenesis | 1.877977e-3 |
GO:0045654 | positive regulation of megakaryocyte differentiation | 1.884209e-3 |
GO:0001886 | endothelial cell morphogenesis | 1.892993e-3 |
GO:0002064 | epithelial cell development | 1.894643e-3 |
GO:0006498 | N-terminal protein lipidation | 1.908083e-3 |
GO:0045542 | positive regulation of cholesterol biosynthetic process | 1.917392e-3 |
GO:0072365 | regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter | 1.932785e-3 |
GO:0007509 | mesoderm migration involved in gastrulation | 1.946178e-3 |
GO:0060606 | tube closure | 1.953849e-3 |
GO:0032060 | bleb assembly | 1.960407e-3 |
GO:0046322 | negative regulation of fatty acid oxidation | 1.970049e-3 |
GO:0001937 | negative regulation of endothelial cell proliferation | 1.970296e-3 |
GO:0007412 | axon target recognition | 1.979708e-3 |
GO:0001558 | regulation of cell growth | 2.012159e-3 |
GO:0007283 | spermatogenesis | 2.020780e-3 |
GO:2000758 | positive regulation of peptidyl-lysine acetylation | 2.065068e-3 |
GO:0043088 | regulation of Cdc42 GTPase activity | 2.072464e-3 |
GO:0045786 | negative regulation of cell cycle | 2.104183e-3 |
GO:0034377 | plasma lipoprotein particle assembly | 2.111652e-3 |
GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan | 2.111652e-3 |
GO:0060433 | bronchus development | 2.154212e-3 |
GO:0050482 | arachidonic acid secretion | 2.154212e-3 |
GO:0016197 | endosome transport | 2.159970e-3 |
GO:0072369 | regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter | 2.203363e-3 |
GO:0072366 | regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter | 2.203363e-3 |
GO:0072363 | regulation of glycolysis by positive regulation of transcription from RNA polymerase II promoter | 2.203363e-3 |
GO:0035802 | adrenal cortex formation | 2.203363e-3 |
GO:0034587 | piRNA metabolic process | 2.230568e-3 |
GO:0002740 | negative regulation of cytokine secretion involved in immune response | 2.263566e-3 |
GO:0003084 | positive regulation of systemic arterial blood pressure | 2.270474e-3 |
GO:0016569 | covalent chromatin modification | 2.283205e-3 |
GO:0043624 | cellular protein complex disassembly | 2.335303e-3 |
GO:0048147 | negative regulation of fibroblast proliferation | 2.354244e-3 |
GO:0032012 | regulation of ARF protein signal transduction | 2.373178e-3 |
GO:0043305 | negative regulation of mast cell degranulation | 2.373395e-3 |
GO:0002876 | positive regulation of chronic inflammatory response to antigenic stimulus | 2.373395e-3 |
GO:0050766 | positive regulation of phagocytosis | 2.396939e-3 |
GO:0008589 | regulation of smoothened signaling pathway | 2.396939e-3 |
GO:0046826 | negative regulation of protein export from nucleus | 2.397690e-3 |
GO:0090130 | tissue migration | 2.399888e-3 |
GO:0090035 | positive regulation of cellular chaperone-mediated protein complex assembly | 2.409140e-3 |
GO:0003338 | metanephros morphogenesis | 2.451547e-3 |
GO:0045085 | negative regulation of interleukin-2 biosynthetic process | 2.509856e-3 |
GO:0071816 | tail-anchored membrane protein insertion into ER membrane | 2.509856e-3 |
GO:0006651 | diacylglycerol biosynthetic process | 2.509856e-3 |
GO:0015914 | phospholipid transport | 2.523326e-3 |
GO:0034623 | cellular macromolecular complex disassembly | 2.539754e-3 |
GO:0010224 | response to UV-B | 2.558462e-3 |
GO:0051321 | meiotic cell cycle | 2.602754e-3 |
GO:0051546 | keratinocyte migration | 2.637754e-3 |
GO:0030252 | growth hormone secretion | 2.637754e-3 |
GO:0009820 | alkaloid metabolic process | 2.658569e-3 |
GO:0045368 | positive regulation of interleukin-13 biosynthetic process | 2.672033e-3 |
GO:0070252 | actin-mediated cell contraction | 2.673531e-3 |
GO:0000738 | DNA catabolic process, exonucleolytic | 2.689475e-3 |
GO:0006695 | cholesterol biosynthetic process | 2.713553e-3 |
GO:0090162 | establishment of epithelial cell polarity | 2.790331e-3 |
GO:0042254 | ribosome biogenesis | 2.837395e-3 |
GO:0006693 | prostaglandin metabolic process | 2.931167e-3 |
GO:0006984 | ER-nucleus signaling pathway | 2.937018e-3 |
GO:0071364 | cellular response to epidermal growth factor stimulus | 2.960893e-3 |
GO:0030307 | positive regulation of cell growth | 3.014990e-3 |
GO:0010893 | positive regulation of steroid biosynthetic process | 3.016625e-3 |
GO:0007126 | meiosis | 3.053091e-3 |
GO:0002019 | regulation of renal output by angiotensin | 3.073763e-3 |
GO:2000065 | negative regulation of cortisol biosynthetic process | 3.081723e-3 |
GO:0070194 | synaptonemal complex disassembly | 3.081723e-3 |
GO:0032348 | negative regulation of aldosterone biosynthetic process | 3.081723e-3 |
GO:0001516 | prostaglandin biosynthetic process | 3.166873e-3 |
GO:0016570 | histone modification | 3.183790e-3 |
GO:0021707 | cerebellar granule cell differentiation | 3.195088e-3 |
GO:0043570 | maintenance of DNA repeat elements | 3.195088e-3 |
GO:0016126 | sterol biosynthetic process | 3.283935e-3 |
GO:0021508 | floor plate formation | 3.306223e-3 |
GO:0071803 | positive regulation of podosome assembly | 3.310791e-3 |
GO:0042363 | fat-soluble vitamin catabolic process | 3.310791e-3 |
GO:0002347 | response to tumor cell | 3.310791e-3 |
GO:0001887 | selenium compound metabolic process | 3.310791e-3 |
GO:0006558 | L-phenylalanine metabolic process | 3.495815e-3 |
GO:0046324 | regulation of glucose import | 3.501958e-3 |
GO:0003382 | epithelial cell morphogenesis | 3.505531e-3 |
GO:0071481 | cellular response to X-ray | 3.573298e-3 |
GO:0006544 | glycine metabolic process | 3.577756e-3 |
GO:0072331 | signal transduction by p53 class mediator | 3.586937e-3 |
GO:0033326 | cerebrospinal fluid secretion | 3.593981e-3 |
GO:0071217 | cellular response to external biotic stimulus | 3.593981e-3 |
GO:0015993 | molecular hydrogen transport | 3.593981e-3 |
GO:0051388 | positive regulation of nerve growth factor receptor signaling pathway | 3.599300e-3 |
GO:0031914 | negative regulation of synaptic plasticity | 3.599300e-3 |
GO:0050713 | negative regulation of interleukin-1 beta secretion | 3.633376e-3 |
GO:0008078 | mesodermal cell migration | 3.633376e-3 |
GO:0045725 | positive regulation of glycogen biosynthetic process | 3.634031e-3 |
GO:0016331 | morphogenesis of embryonic epithelium | 3.634601e-3 |
GO:0048755 | branching morphogenesis of a nerve | 3.658796e-3 |
GO:0043457 | regulation of cellular respiration | 3.658796e-3 |
GO:0007549 | dosage compensation | 3.664483e-3 |
GO:0002444 | myeloid leukocyte mediated immunity | 3.684450e-3 |
GO:0035518 | histone H2A monoubiquitination | 3.755618e-3 |
GO:0070086 | ubiquitin-dependent endocytosis | 3.771514e-3 |
GO:0051447 | negative regulation of meiotic cell cycle | 3.771514e-3 |
GO:0070846 | Hsp90 deacetylation | 3.771514e-3 |
GO:0090042 | tubulin deacetylation | 3.771514e-3 |
GO:0042840 | D-glucuronate catabolic process | 3.771514e-3 |
GO:0002462 | tolerance induction to nonself antigen | 3.771514e-3 |
GO:0034776 | response to histamine | 3.771514e-3 |
GO:0006419 | alanyl-tRNA aminoacylation | 3.864064e-3 |
GO:0042756 | drinking behavior | 3.866128e-3 |
GO:0046834 | lipid phosphorylation | 3.947177e-3 |
GO:0070875 | positive regulation of glycogen metabolic process | 4.024565e-3 |
GO:0030035 | microspike assembly | 4.189963e-3 |
GO:0060850 | regulation of transcription involved in cell fate commitment | 4.199702e-3 |
GO:0034725 | DNA replication-dependent nucleosome disassembly | 4.202371e-3 |
GO:0035039 | male pronucleus assembly | 4.202371e-3 |
GO:0032298 | positive regulation of DNA-dependent DNA replication initiation | 4.202371e-3 |
GO:0019556 | histidine catabolic process to glutamate and formamide | 4.202371e-3 |
GO:0048546 | digestive tract morphogenesis | 4.260748e-3 |
GO:0034653 | retinoic acid catabolic process | 4.297048e-3 |
GO:0032509 | endosome transport via multivesicular body sorting pathway | 4.297048e-3 |
GO:0007422 | peripheral nervous system development | 4.333106e-3 |
GO:0072179 | nephric duct formation | 4.505034e-3 |
GO:0030010 | establishment of cell polarity | 4.571676e-3 |
GO:0060648 | mammary gland bud morphogenesis | 4.575865e-3 |
GO:0032873 | negative regulation of stress-activated MAPK cascade | 4.575865e-3 |
GO:0070286 | axonemal dynein complex assembly | 4.616070e-3 |
GO:0021898 | commitment of multipotent stem cells to neuronal lineage in forebrain | 4.616070e-3 |
GO:0050995 | negative regulation of lipid catabolic process | 4.666511e-3 |
GO:0016072 | rRNA metabolic process | 4.732272e-3 |
GO:0034695 | response to prostaglandin E stimulus | 4.765868e-3 |
GO:0071295 | cellular response to vitamin | 4.787012e-3 |
GO:0060487 | lung epithelial cell differentiation | 4.835192e-3 |
GO:0051000 | positive regulation of nitric-oxide synthase activity | 4.886587e-3 |
GO:0002031 | G-protein coupled receptor internalization | 4.938831e-3 |
GO:0015760 | glucose-6-phosphate transport | 4.971769e-3 |
GO:0021683 | cerebellar granular layer morphogenesis | 4.976770e-3 |
GO:0006705 | mineralocorticoid biosynthetic process | 5.038086e-3 |
GO:0014034 | neural crest cell fate commitment | 5.038086e-3 |
GO:0009071 | serine family amino acid catabolic process | 5.038456e-3 |
GO:0009048 | dosage compensation, by inactivation of X chromosome | 5.047604e-3 |
GO:0046825 | regulation of protein export from nucleus | 5.233828e-3 |
GO:0032613 | interleukin-10 production | 5.417965e-3 |
GO:0048565 | digestive tract development | 5.526563e-3 |
GO:0021892 | cerebral cortex GABAergic interneuron differentiation | 5.553979e-3 |
GO:0002446 | neutrophil mediated immunity | 5.578218e-3 |
GO:0070508 | cholesterol import | 5.618126e-3 |
GO:0032984 | macromolecular complex disassembly | 5.635478e-3 |
GO:0016338 | calcium-independent cell-cell adhesion | 5.635478e-3 |
GO:0010596 | negative regulation of endothelial cell migration | 5.693584e-3 |
GO:0046626 | regulation of insulin receptor signaling pathway | 5.699096e-3 |
GO:0030330 | DNA damage response, signal transduction by p53 class mediator | 5.782384e-3 |
GO:0002320 | lymphoid progenitor cell differentiation | 5.848752e-3 |
GO:0060677 | ureteric bud elongation | 5.919337e-3 |
GO:0045082 | positive regulation of interleukin-10 biosynthetic process | 5.919337e-3 |
GO:0045128 | negative regulation of reciprocal meiotic recombination | 6.021755e-3 |
GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus | 6.021755e-3 |
GO:0043985 | histone H4-R3 methylation | 6.021755e-3 |
GO:0006561 | proline biosynthetic process | 6.021755e-3 |
GO:0006311 | meiotic gene conversion | 6.021755e-3 |
GO:0001843 | neural tube closure | 6.074862e-3 |
GO:0060710 | chorio-allantoic fusion | 6.124065e-3 |
GO:0032098 | regulation of appetite | 6.124065e-3 |
GO:0070265 | necrotic cell death | 6.143184e-3 |
GO:0021515 | cell differentiation in spinal cord | 6.154625e-3 |
GO:0070050 | neuron homeostasis | 6.240389e-3 |
GO:0030225 | macrophage differentiation | 6.282285e-3 |
GO:0007015 | actin filament organization | 6.326421e-3 |
GO:0035247 | peptidyl-arginine omega-N-methylation | 6.353930e-3 |
GO:0072189 | ureter development | 6.362119e-3 |
GO:0001825 | blastocyst formation | 6.415972e-3 |
GO:0046853 | inositol or phosphatidylinositol phosphorylation | 6.448690e-3 |
GO:0060730 | regulation of intestinal epithelial structure maintenance | 6.448690e-3 |
GO:0048295 | positive regulation of isotype switching to IgE isotypes | 6.448690e-3 |
GO:0035883 | enteroendocrine cell differentiation | 6.448690e-3 |
GO:0001998 | angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure | 6.448690e-3 |
GO:0051451 | myoblast migration | 6.448863e-3 |
GO:0035441 | cell migration involved in vasculogenesis | 6.448863e-3 |
GO:0046628 | positive regulation of insulin receptor signaling pathway | 6.482093e-3 |
GO:0033688 | regulation of osteoblast proliferation | 6.544416e-3 |
GO:0003215 | cardiac right ventricle morphogenesis | 6.682235e-3 |
GO:0002017 | regulation of blood volume by renal aldosterone | 6.683955e-3 |
GO:0001834 | trophectodermal cell proliferation | 6.683955e-3 |
GO:0002579 | positive regulation of antigen processing and presentation | 6.689175e-3 |
GO:0042520 | positive regulation of tyrosine phosphorylation of Stat4 protein | 6.710424e-3 |
GO:0048148 | behavioral response to cocaine | 6.710424e-3 |
GO:0032530 | regulation of microvillus organization | 6.727189e-3 |
GO:0006308 | DNA catabolic process | 6.748207e-3 |
GO:0043241 | protein complex disassembly | 6.794990e-3 |
GO:0002149 | hypochlorous acid biosynthetic process | 6.839381e-3 |
GO:0060231 | mesenchymal to epithelial transition | 6.879202e-3 |
GO:0060413 | atrial septum morphogenesis | 6.880067e-3 |
GO:0007217 | tachykinin receptor signaling pathway | 6.896856e-3 |
GO:0060066 | oviduct development | 6.941300e-3 |
GO:0006306 | DNA methylation | 7.079453e-3 |
GO:0051534 | negative regulation of NFAT protein import into nucleus | 7.233366e-3 |
GO:0006213 | pyrimidine nucleoside metabolic process | 7.343959e-3 |
GO:0048145 | regulation of fibroblast proliferation | 7.499076e-3 |
GO:0060539 | diaphragm development | 7.542043e-3 |
GO:0035313 | wound healing, spreading of epidermal cells | 7.565082e-3 |
GO:0033689 | negative regulation of osteoblast proliferation | 7.571718e-3 |
GO:0060879 | semicircular canal fusion | 7.619204e-3 |
GO:0019918 | peptidyl-arginine methylation, to symmetrical-dimethyl arginine | 7.619204e-3 |
GO:0070075 | tear secretion | 7.619204e-3 |
GO:0070352 | positive regulation of white fat cell proliferation | 7.619204e-3 |
GO:0060661 | submandibular salivary gland formation | 7.619204e-3 |
GO:0061115 | lung proximal/distal axis specification | 7.619204e-3 |
GO:0050674 | urothelial cell proliferation | 7.619204e-3 |
GO:0050677 | positive regulation of urothelial cell proliferation | 7.619204e-3 |
GO:0060436 | bronchiole morphogenesis | 7.619204e-3 |
GO:0060496 | mesenchymal-epithelial cell signaling involved in lung development | 7.619204e-3 |
GO:0016051 | carbohydrate biosynthetic process | 7.636254e-3 |
GO:0060711 | labyrinthine layer development | 7.713502e-3 |
GO:0030219 | megakaryocyte differentiation | 7.752243e-3 |
GO:0048630 | skeletal muscle tissue growth | 7.758627e-3 |
GO:0051764 | actin crosslink formation | 7.908096e-3 |
GO:0060046 | regulation of acrosome reaction | 8.193862e-3 |
GO:0035564 | regulation of kidney size | 8.193862e-3 |
GO:0043278 | response to morphine | 8.268433e-3 |
GO:0006471 | protein ADP-ribosylation | 8.320992e-3 |
GO:0090263 | positive regulation of canonical Wnt receptor signaling pathway | 8.393028e-3 |
GO:0001999 | renal response to blood flow involved in circulatory renin-angiotensin regulation of systemic arterial blood pressure | 8.462535e-3 |
GO:0007140 | male meiosis | 8.465578e-3 |
GO:0051125 | regulation of actin nucleation | 8.553886e-3 |
GO:0032933 | SREBP-mediated signaling pathway | 8.580653e-3 |
GO:0033004 | negative regulation of mast cell activation | 8.644146e-3 |
GO:0046364 | monosaccharide biosynthetic process | 8.667147e-3 |
GO:0034259 | negative regulation of Rho GTPase activity | 8.967105e-3 |
GO:0003108 | negative regulation of the force of heart contraction by chemical signal | 8.967105e-3 |
GO:0030719 | P granule organization | 9.030027e-3 |
GO:0002874 | regulation of chronic inflammatory response to antigenic stimulus | 9.030027e-3 |
GO:0032805 | positive regulation of low-density lipoprotein particle receptor catabolic process | 9.030722e-3 |
GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 9.030722e-3 |
GO:0018120 | peptidyl-arginine ADP-ribosylation | 9.030722e-3 |
GO:0032241 | positive regulation of nucleobase-containing compound transport | 9.030722e-3 |
GO:0045404 | positive regulation of interleukin-4 biosynthetic process | 9.107753e-3 |
GO:0007182 | common-partner SMAD protein phosphorylation | 9.107753e-3 |
GO:0007621 | negative regulation of female receptivity | 9.112703e-3 |
GO:0061156 | pulmonary artery morphogenesis | 9.332166e-3 |
GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 9.332166e-3 |
GO:0045630 | positive regulation of T-helper 2 cell differentiation | 9.332166e-3 |
GO:0002604 | regulation of dendritic cell antigen processing and presentation | 9.357082e-3 |
GO:0003290 | atrial septum secundum morphogenesis | 9.373951e-3 |
GO:0045218 | zonula adherens maintenance | 9.373951e-3 |
GO:0006663 | platelet activating factor biosynthetic process | 9.373951e-3 |
GO:0045332 | phospholipid translocation | 9.491129e-3 |